Dexepicatechin

DB19253InvestigationalSmall molecule

Dexepicatechin is under investigation in clinical trial NCT02964377 (Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory Adolescents).

Chemical structure of Dexepicatechin
Mechanism
Curator reviewed
Formula / weight
C15H14O6 · 290.271 g/mol (avg)
Also known as
(+)- Epicatechin · (+)-Epicatechin · (2s,3s)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol · 2h-1-benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2s-cis)- · D-epicatechin

Resolves to

Compound
UNIILD6B6TT8Q5CAS35323-91-2ChEMBLCHEMBL129482ChEBI76125KEGGC09728
Structure
InChIKeyPFTAWBLQPZVEMU-ZFWWWQNUSA-NSMILESO[C@H]1CC2=C(O)C=C(O)C=C2O[C@H]1C1=CC=C(O)C(O)=C1
Targets
P40763STAT3

What you can answer from here — as of July 19, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Dexepicatechin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In